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Abstract
Background: Skin stem cells contribute to all three major lineages of epidermal appendages, i.e., the epidermis,
the hair follicle, and the sebaceous gland. In hair follicles, highly proliferative committed progenitor cells, called
matrix cells, are located at the base of the follicle in the hair bulb. The differentiation of these early progenitor cells
leads to specification of a central hair shaft surrounded by an inner root sheath (IRS) and a companion layer.
Multiple signaling molecules, including bone morphogenetic proteins (BMPs), have been implicated in this process.
Methods: To further probe the contribution of BMP signaling to hair follicle development and maintenance we
employed a transgenic mouse that expresses the BMP inhibitor, Noggin, to disrupt BMP signaling specifically in
subset of hair follicle progenitors under the control of neuron specific enolase (Nse) promoter. We then studied
the skin tumor phenotypes of the transgenic mice through histology, immunohistochemistry and Western Blotting
to delineate the underlying mechanisms. Double transgenic mice expressing BMP as well as noggin under control
of the Nse promoter were used to rescue the skin tumor phenotypes.
Results: We found that the transgene is expressed specifically in a subpopulation of P-cadherin positive progenitor
cells in Nse-Noggin mice. Blocking BMP signaling in this cell population led to benign hair follicle-derived
neoplasias resembling human trichofolliculomas, associated with down-regulation of E-cadherin expression and
dynamic regulation of CD44.
Conclusions: These observations further define a critical role for BMP signaling in maintaining the homeostasis of
hair follicles, and suggest that dysregulation of BMP signaling in hair follicle progenitors may contribute to human
trichofolliculoma.
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Background
The skin is a barrier that protects against the physical,
chemical, and thermal assaults of the environment. To
serve these functions, epidermis generates an elaborate
array of supportive appendages, including hair follicles
(HFs), sebaceous glands, sweat glands, and nails [1].
Many conserved signal molecules, such as WNT[2],
NOTCH[3], FGF[4], Hedgehog[5] and BMP[6], are
involved in orchestrating the development and
maintenance of this important organ. Not surprisingly,
disruption of BMP signaling has been implicated in an
array of skin disorders.
BMP signaling plays essential roles in many biological
processes in numerous types of cells and tissues during
embryonic development and adult life [7]. BMP actions
are regulated in vivo in a time and location-dependent
manner by proteins such as noggin, gremlin, chordin
and others that antagonize BMP signaling by directly
binding BMPs and their immediate downstream media-
tors, thus blocking ligand activity [8]. Not surprisingly,
the phenotypes generated from disrupting BMP signal-
ing through loss-of-function or gain-of-function muta-
tions are temporally, spatially, and dosage-dependent.
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to embryonic lethality [9,10], whereas inhibition of BMP
signaling by overexpressing Noggin under control of dif-
ferent promoters, or by conditional knockout of BMP
receptor subunits, leads to variable phenotypes. Many of
these mutant animals show strong cutaneous phenotypes
that resemble human skin disorders. Further study along
this line will deepen our understanding of the normal
role of BMP signaling in skin and supportive appendages.
Here we utilized transgenic mice that overexpress
noggin under control of the neuron-specific enolase
(Nse) promoter [11] to further probe the role of BMP
signaling in orchestrating proliferation and differentia-
tion of epidermal progenitors. We found that overex-
pression of Noggin in P-cadherin positive hair
progenitor cells led to benign hair follicle-derived neo-
plasias resembling human trichofolliculomas.
Trichofolliculoma (also called folliculoma, or hair folli-
cle nevus) is a benign highly structured hamartoma of
the pilosebaceous unit. The morphologic features of tri-
chofolliculoma are variable, reminiscent of the anagen,
catagen, and telogen phases of a normal hair follicle in
its cycle. However, the follicular epithelium usually exhi-
bits a distinct granular cell layer similar to the normal
follicular infundibulum. Follicles or follicle-like struc-
tures branch to form secondary or tertiary units. Tricho-
keratin, not real hair, may be found enclosed in the
follicle matrix cells, and the stroma is moderately cellu-
lar and loosely organized similar to that found in the
normal follicle. These characteristic histological features
distinguish this disorder from similar skin disorders
such as dilated pore of winer, trichoepithelioma, follicu-
losebaceous cystic hamartoma [12], pilomatricomas or
sebaceous trichofolliculoma[ 1 3 ] .H o w e v e r ,t h ep r e c i s e
etiology of trichofolliculoma is still unknown.
Our current study of a trichofolliculoma-like pheno-
type in Nse-Noggin mice indicated that blocking BMP
signaling in hair follicle progenitors is associated with
d o w n - r e g u l a t i o no fE - c a d h e r i ne x p r e s s i o na n ds u b s e -
quent dosage dependent up-regulation of CD44. Com-
plimentary to a previous report [14], we also observed
dysregulation of b-catenin signaling in tumor cells. This
study not only provides additional evidence of the
importance of BMP signaling in maintaining the home-
ostasis of hair follicles, but also may help to further




Previously generated Nse-Noggin and Nse-BMP4 mice
were used in this study [15,16]. All animal experiments
in this study were approved by the Animal Care and
Use Committee at Northwestern University.
Histology and immunohistochemistry
Hematoxylin and eosin staining was performed on fixed
tissue sections using Harris Modified Hematoxylin and
Eosin Y Solution (Sigma, St. Louis, MO), according to
the manufacturer’s instructions. Immunostaining was
done using standard protocols [17]. Briefly, sections
were fixed with 4% paraformaldehyde in PBS. Non-spe-
cific binding was blocked with 10% normal serum
diluted in 1% bovine serum albumin (BSA, Jackson Lab,
USA) and 0.25% Triton X-100 for one hour in room
temperature. The sections were then incubated with pri-
mary antibodies diluted with 1% BSA + 0.25% Triton X-
100 at 4°C overnight. The sections were then incubated
with appropriate secondary antibodies (Cy3 or Cy2 con-
jugated antibodies (Jackson Lab) diluted with 1% BSA +
0.25% Triton X-100 or Alexa Fluor 488, Alexa Fluor
594, and Alexa 647 (1:1000, Invitrogen)) in the dark at
room temperature for 2 hours. Counterstaining was
then performed with DAPI (1:5000). Fluorescent images
were processed by Adobe Photoshop. Anti-Ki67 (Novus
Biologicals), anti-total b-cat (Santa Cruz Biotechnology
Inc), anti-phospho b-cat (Thr41/Ser45) (cell signaling),
anti-active b-cat (clone 8E7, Millipore), and NSE (Bio-
Genex), anti-K14 (covance) are used in this study.
Western blot analysis
Protein levels of CD44 and P-cad in tissue were mea-
sured by Western blotting. Tissues were homogenized
in protein extract buffer (Roche) and homogenized sam-
ples (20 μg of protein) were subjected to 4-20%
SDSPAGE gradient gel (Bio-Rad) under reducing condi-
tions. The CD44 was identified by Rat anti-mouse CD44
(BD Bioscience) and P-cad was identified by mouse
anti-p-cad antibody (BD Bioscience). The membranes
were incubated with the secondary antibodies (Biotiny-
lated goat anti-rat IgG and Biotinylated goat anti-mouse
IgG1) (Santa Cruz Biotechnology Inc) for 1 hr at room
temperature. Blots were developed by the ECL Western
blotting detection reagents (Perkin-Elmer).
Statistical Analyses
Values are expressed as means ± standard deviation of
the mean, and p < 0.05 is considered to be statistical
significance. Intergroup comparisons were made using
two-way ANOVA. The photographs shown represent
the results obtained from three independent
experiments.
Results
The noggin transgene is expressed in P-cadherin positive
hair progenitor cells in Nse-Noggin mice
Noggin overexpression under different promoters leads
to a spectrum of phenotypes due to differing temporal
and spatial patterns of transgene expression [18-21]. We
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the BMP inhibitor noggin under control of the Nse pro-
moter (Nse-noggin) to examine the role of BMP signal-
ing in development of the brain. We noticed that Nse-
Noggin mice have a dramatic hair phenotype [16] and
that substantial numbers of adult Nse-noggin mice also
developed skin tumors.
To begin to understand how inhibition of BMP signal-
ing in this mouse model leads to tumorigenesis, we first
examined the pattern of transgene expression in skin.
Since the transgene has an IRES-GFP tag in this line, we
could easily track transgene expression cells by epifluor-
escence of GFP (Figure. 1A). Previous studies indicated
that the transgene is over-expressed under this promo-
ter in neurons from the late embryonic stage onward
[15]. Our current study found that transgene was also
expressed in a subpopulation of hair follicle cells from
late embryonic stages onward (Figure 1B-D). Double
staining for GFP and for either keratin 14 (K14, a fully
differentiated keratinocyte marker) or P-cadherin, a hair
follicle progenitor marker in skin [22], indicated that the
transgene is expressed by a subpopulation of hair follicle
progenitor cells, but not by fully differentiated keratino-
cytes (Figure 1E&F). To clarify whether this transgene
expression pattern reflects the endogenous Nse promo-
ter activity, we stained WT skin samples with a specific
monoclonal antibody that recognizes endogenous NSE
p r o t e i n .W ef o u n dt h a te n d o g e n o u sN S Ei sh i g h l y
expressed in a subpopulation of hair follicle cells (Figure
1G). Consistently, extensive co-localization of NSE and
the GFP transgene tag was observed in tumor cells (Fig-
ure 1H).
Blocking BMP signaling in hair progenitor cells induces
benign hair follicle-derived neoplasias resembling
trichofolliculomas
A st h et r a n s g e n i cm i c em a t u r e dt h e yd e v e l o p e ds k i n
tumors. The size and location of tumors varied greatly,
and some mice developed multiple tumors. Detailed his-
tological study found that these tumors consistently
recapitulated the characteristic histological features of
human trichofolliculomas, i.e., the follicular epithelium
exhibits a distinct granular cell layer similar to the nor-
mal follicular infundibulum. Follicles or follicle-like
structures branch to form complex secondary or tertiary
units, and such secondary or tertiary follicles display fea-
tures of lower segment differentiation, such as a hair
bulb, or the presence of a hair shaft. The stroma, on the
Figure 1 The Noggin transgene is expressed in P-cadherin positive hair progenitor cells in Nse-Noggin mice from late embryonic
stages onward. (A) Schematic structure of Nse-Noggin transgene. (B-D) typical images of tail skin of Nse-Noggin mice show the specific
transgene (GFP) expression pattern. GFP positive cells are detected in hair buds from E16 (B) In postnatal animals (P0(C) & P6(D)) transgene
expression is also observed only in subpopulations of hair follicles (C&D). (E-F) double staining confirms that the transgene is expressed in hair
progenitors (P-cadherin Positive, E-E”) but not in fully differentiated epithelium (K14 positive, F). (E) shows typical GFP/P-cadherin double staining
of a hair follicle from an adult Nse-Noggin animal. E’&E ” are the split channels of P-cadherin and GFP, respectively. (F) shows typical GFP/K14
double staining of a hair follicle from an E18 Nse-Noggin mouse. (G) shows typical NSE staining of a hair follicle from an adult WT animal. Note
that NSE is highly expressed in a subpopulation of hair follicle cells. (H-H”) shows typical GFP/NSE double staining of well developed tumor
section. H’&H ” are the split channels of NSE and GFP, respectively. Bar = 40 μm.
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t h en o r m a lf o l l i c l e( F i g u r e2 ) .A l k a l i n ep h o s p h a t a s e
staining confirmed that dermal papillae are present in
tumor (Figure 2E-H). Detailed histological study of
tumors taken from mice at different stages of tumori-
genesis revealed that blocking BMP signaling in hair
progenitors induced ordered transformation, hyperplasia,
and finally neoplasias resembling trichofolliculomas (Fig-
ure 3). This slow and orderly tumorigenesis process may
take a few months to finish.
Nse-BMP4 rescued the tumor phenotype in Nse-Noggin
mice
To further prove that the observed tumor phenotype is
BMP signaling dependent, not due to the nonspecific
positional effort of transgene integration, we generated
N s e - B M P 4 ; N s e - N o g g i nd o u b l et r a n s g e n i cm i c eb ym a t -
ing Nse-BMP4 with Nse-Noggin mice. The rationale of
this experiment is that if the tumor phenotype is caused
by specifically inhibiting BMP signaling, overexpression
of BMP4 under the same promoter could at least par-
tially block the inhibition. We found none of the Nse-
B M P 4 ; N s e - N o g g i nd o u b l et r a n s g e n i cm i c ed e v e l o p
observable tumors. Histological study confirmed this
observation, even though subtle hyperplasia of hair folli-
cles is still observable in double transgenic mice (Figure
4). This data confirmed that noggin exerted its effects
specifically by inhibiting BMP signaling.
Mechanisms of Noggin induced tumorigenesis
When E-cadherin is transgenically elevated in mouse
skin, hair follicle morphogenesis is blocked, suggesting
that E-cadherin down-regulation is a critical event in
the adhesion dynamics governing morphogenesis of hair
follicles [23]. To help clarify the specific molecular and
cellular mechanisms underlying tumorigenesis in Nse-
Noggin mice, we double stained sections of tumor for
E-Cadherin, a normal basal epithelium marker, and for
P-Cadherin, a marker of hair progenitor cells. Expres-
sion of P-Cadherin was significantly up-regulated in
GFP positive cells. By contrast, E-Cadherin was down-
regulated not only in GFP positive tumor cells, but also
in normal basal epithelia adjacent to the tumor (Figure
5). Thus inhibition of BMP signaling differentially dis-
rupts the composition of cell adhesion proteins that are
essential for maintaining the architecture of normal
skin. The net effect is to prevent hair progenitor cells
from differentiating, while maintaining the proliferation
of keratinocyte lineage. Consistently, Ki67, a cell prolif-
eration marker, was dramatically up-regulated in tumor
cells, indicating that tumor cells remained in the cell
cycle and were not terminally differentiated (Figure 5).
To further explore different aspects of tumorigenesis,
we double stained for GFP and CD44, a transmembrane
receptor that is implicated in cell migration [24]. Pre-
vious studies have indicated that CD44 overexpression
and activation plays a role in the trafficking of meta-
static cancer to distant sites [24]. This receptor was also
dynamically regulated by BMP signaling during tumori-
genesis in a dosage-depend way, i.e., cells that expressed
low levels of GFP/Noggin had strong CD44 staining
while cells that expressed high levels of GFP/noggin had
minimal CD44 expression. The overall CD44 expression
level, however, was not up-regulated in tumor. This
finding was confirmed by Western blotting (Figure 6).
A previous report indicated that overexpressing stabi-
lized b-catenin specifically in the epidermis and follicle
outer root sheath induced two types of tumors that
resemble trichofolliculomas and pilomatricomas[14]. To
clarify if b-catenin is dysregulated in our model, we pre-
formed additional immunostaining for total b-catenin,
phosphorylated b-catenin, and active/stable b-catenin,
and we found that both total b-catenin and phosphory-
lated b-catenin were down-regulated in the tumor, espe-
cially in the hair follicle derived cells (Figure 7A-D). In
contrast, even though no obvious change was found in
the majority of tumor cells, active/stable beta-catenin
was dramatically up-regulated in a minor subpopulation
of cells (Figure 7E&F). Further study found that the
high levels of stable b-catenin almost exclusively co-
localized with a dermal papillae marker (ALP) (Figure
7G).
Discussion
Mammalian skin begins as a single sheet of multipotent
ectodermal cells. The development of a hair follicle
requires a series of coordinated changes in the behavior
of the targeted cells within an epithelial sheet [1]. The
process must be accompanied by alterations in the pro-
liferation, polarity, shape, and adhesiveness of selected
cells. BMP signaling plays a major role in numerous
stages of this process. Consequently loss-of-function
mutations in BMP signaling at different developmental
stages or locations within the epithelium leads to strik-
ingly different phenotypes, consistent with many prior
studies that have shown developmental changes in the
functions of growth factors [25].
Conditional null mutation of the BMP type IA recep-
tor (BMPRIA) through cre-mediated recombination dri-
ven by different promoters leads to different
phenotypes. For example, knockout of BMPR-IA
through K14-Cre mediated recombination leads to
severe defects in the inner root sheath and hair shaft
differentiation, retardation of catagen and formation of
hair follicles-derived tumors with age [26]. By contrast,
knockout of BMPR-IA through Emx1-Cre mediated
recombination, leads to defects in the inner root sheath
differentiation, formation of cysts in the hair canal [6].
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Page 4 of 12Figure 2 Blocking BMP signaling in hair progenitor cells induces benign hair follicle-derived neoplasias resembling trichofolliculomas.
(A) Gross image show the sizes and locations of neoplasias in three different mice. Note that the sizes and locations vary in different mice. Black
arrows point to neoplasias. (B-C) typical low power H&E images from a fully developed neoplasia from back skin (B) and tail (C). Note the well-
formed fibrous sheath that surrounds the outer surface of tumor. Also note that a fully developed neoplasia from back skin was over 1 cm in
diameter. Neoplasias that grow on the tail are relatively small, and are not well wrapped(C), but nevertheless both show typical histological
features of trichofolliculomas. (D) High power H&E image from a tail tumor shows multiple abnormal secondary hair follicle-like structures
surrounded by fibroblast-like stroma cells. (E-H) two independent alkaline phosphatase assays indicated that dermal papillae are present in
tumor. (E&F) tested the enzymatic activity of alkaline phosphatase in WT tail skin (E) and tumor (F). Note the strong blue ALP staining in WT hair
follicle and tumor (yellow to brown in (E&F) is background staining). (G&H) detect the alkaline phosphatase antigen in WT tail skin (G) and tumor
(H) through standard IHC. Note, similar to (E&F), strong ALP staining was detected in both WT hair follicle and tumor. Bar = 40 μm in (D-H).
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mediated recombination leads to severe defects in the
inner root sheath and hair shaft formation in ventral
hair follicles [27].
Interestingly, both pro- and anti-tumor effects of BMP
signaling have been reported in the literature. For exam-
ple, loss-of-function mutations in human of either
MADH4 (which encodes SMAD4, the downstream tran-
scription factor that mediates the BMP signaling) or
BMPRIA are associated with juvenile polyposis syn-
drome [28]. Further, conditional knockout of Smad4
through MMTV-Cre mediated recombination leads to
squamous cell carcinoma formation [29]. BMP signaling
also exerts anti-tumor effects in cytokeratin IV-BMP-4
transgenic mice skin that resist the TPA (phorbol ester
12-O-tetradecanoylphorbol-13-acetate) induced papillo-
mas and squamous cell carcinomas formation [30]. By
contrast, BMP proteins are highly over-expressed in
human non-small cell lung carcinoma and recombinant
BMP-2 enhances the growth of tumors formed from
A549 cells injected subcutaneously into nude mice [31].
Further, BMP-4 mRNA is preferentially overexpressed
in poorly differentiated gastric cancer [32], and overex-
pression of BMP-2/4, -5 or BMPR-IA are all associated
with malignancy of oral epithelium and may be involved
in the metastasis of oral carcinoma cells [33]. Thus, the
biological responses to BMP signaling are cell type and/
or context dependent.
More importantly, even overexpressing Noggin in skin
under different promoters leads to a spectrum of pheno-
types. For example, Msx2-Noggin transgenic mice lack
external hairs due to severe alterations in hair shaft for-
mation [34]; K5-Noggin transgenic mice have retarded
epidermal differentiation and reduced apoptosis [19];
K14-Noggin transgenic mice have a thickened epidermis
with formation of compound vibrissa hair follicles [35].
Note that none of these studies reported tumorigenesis
in these mice.
This study using the Nse-Noggin mouse model, as
well as a prior study involving noggin overexpression in
Figure 3 Blocking BMP signaling in hair progenitor cells induces ordered tumorigenesis. (A1-A3) H&E images from different time points of
Nse-Noggin animals show morphological features of neoplasias at different stages of tumorigenesis. Note the progressive development of
abnormal secondary hair follicles. (B1-B3) show the typical transgene expression pattern at different stages of tumorigenesis. Note that transgene
expression is restricted to hair follicle cells and not other cells. Bar = 40 μm.
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signaling may play a role in tumorigenesis. Specifically,
we found that inhibition of BMP signaling by overex-
pression of Noggin in hair follicles resulted in formation
of tumors that resemble trichofolliculomas, a relatively
uncommon hair follicle-derived neoplasia.
Presumably the phenotype of Nse-Noggin mice is dif-
ferent from the other cutaneous Noggin transgenic mice
because of differences in the expression patterns of the
transgenes. In fact, in both K14-Noggin and K5-Noggin
transgenic mice the transgene is overexpressed predomi-
nately in fully differentiated keratinocytes instead of hair
follicle progenitors as in the Nse-Noggin mice. Similarly,
in Msx2-Noggin transgene mice expression of transgene
is also largely seen in differentiated epithelial cells of the
precortex and hair shaft region. Our observations that
Figure 4 Nse-BMP4;Nse-Noggin double transgenic mice show only subtle hyperplasia of hair follicles. Representative H&E staining from
WT (A), Nse-Noggin (B), Nse-BMP4 (C) and Nse-Noggin; Nse-BMP4 double transgenic mice (D) show histological features in different lines of
animals. Note that crossing the Nse-Noggin mice with Nse-BMP4 mice rescued the tumor phenotype seen in Nse-Noggin mice (comparing
B&D), but subtle hyperplasia of hair follicles is still observable in (D). Bar = 40 μm (E) summary of severity of tumorigenesis in different lines.
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the cell cycle and down regulate E-cadherin expression
(both are key events for tumorigenesis) further argue
that this specific transgene pattern might be crucial for
the tumorigenesis. Importantly, mating these mice with
BMP4 transgenic mice under the same promoter res-
cued the tumor phenotype indicating that inhibition of
BMP signaling mediated the effects of the noggin
transgene.
More interestingly, significantly different phenotypes
are even found in transgenic mice that used the same
promoter. For example, both Plikus M et al. [35] and
Sharov AA et al. [36] studied the phenotypes of K14-
Noggin transgenic mice. Sharov AA et al. found that
Figure 5 Blocking BMP signaling in hair progenitor cells disrupts expression of key molecules that are essential for normal
morphogenesis of hair follicles. (A) shows typical GFP/P-cad double staining of a neoplasia from an Nse-Noggin mouse. Note that P-cad is
over expressed in GFP positive cells. (A’&A ”) show the split channel of GFP and P-cad, respectively. (B&C) show typical GFP/E-cad double
staining of a tail neoplasia (B) and a section of WT tail tissue (C). Note that E-cad is normally expressed in basal epithelia and inner root sheath
of tail. This normal expression is dramatically reduced not only in tumor cells but also in the basal epithelia adjacent to tumor. (D) shows typical
GFP/CD44 double staining of a neoplasia. Note the clear inverse relationship of GFP and CD44 expression, i.e., secondary hair follicles that have
strong GFP expression always have low CD44 expression. (D’&D”) show the split channels of CD44 and GFP, respectively. (E&F) show typical Ki67
staining of a tail neoplasia (E) and a section of WT tail tissue (F). Note that, normally, a subpopulation of basal epithelia has strong expression of
Ki67, but very few hair follicle cells are Ki67 positive. Ki67 positive cells are dramatically increased in the tumor. In contrast, Ki67 expression is
reduced in the basal epithelia that adjacent to tumor. Bar = 40 μm.
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spontaneous hair follicle-derived tumors which resemble
human trichofolliculomas. In contrast, Plikus et al.
observed thickened skin epidermis, increased hair den-
sity, altered hair types, faster anagen re-entry, and for-
mation of compound vibrissa follicles in their transgenic
mice (C57BL/6J background). Mouse strain differences
could have contributed to altered tumorigenicity of
K 1 4 - N o g g i n ,h o w e v e r ,w eo b s erved similar tumorigeni-
city in both FVB and C57BL/6J backgrounds (data not
shown).
Complementary to a previous study [14], we also
observed dysregulation of b-catenin signaling in tumor
cells, but our finding is significantly different from Gat
U et al.’s report. Specifically, we found that both total b-
catenin and phosphorylated b-catenin are down-regu-
lated in the tumor, especially in the hair follicle derived
cells. In contrast, even though no obvious change was
found in majority of tumor cells, active/stable beta-cate-
nin was dramatically up-regulated in dermal papillae.
Both studies suggest that dysregulation of b-catenin can
lead to hair follicle tumorigenesis, either directly or
indirectly. However another study has found that noggin
can promote skin tumorigenesis via stimulation of the
Wnt and Shh signaling pathways [36], so the precise
molecular mechansims underlying tumor formation in
our animals remain unclear. However the observation
that Nse-Noggin develops a phenotype that closely
resembles human trichofolliculomas, not other similar
human skin disorders, suggests that disrupted BMP sig-
naling in hair progenitors may specifically contribute to
human trichofolliculomas.
Conclusions
Our observations indicate that inhibition of BMP signal-
ing in P-cadherin positive progenitor cells leads to up-
Figure 6 Western blot analysis confirms that expression of CD44 and P-cad is differentially regulated. (A)Western Blotting using skin
lysates from Nse-BMP4, WT and Nse-Noggin mice. Each lane represents lysate from an individual animal. Nse-BMP4 (lane 1-3), WT (lane 4-6),
Nse-Noggin (lane 7-9). Lane 7 represents lysate from a well-developed tumor, while lane 8&9 represent pre-neoplasia lysates from two individual
Nse-Noggin mice. Top panel shows CD44 expression. Notice that CD44 is not up-regulated in Nse-Noggin tumors generally, which is consistent
with the double-staining finding in (Figure 3D). Middle panel shows P-cad expression. Note that P-cad expression is dramatically up-regulated
only in well-developed tumor. (B&C) quantify the protein expression of P-cad and CD44, respectively. *, differs from WT by ANOVA at p < 0.01.
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Page 9 of 12Figure 7 b-catenin signaling is dysregulated in the tumor. (A&B) show that total b-catenin is down-regulated in tumor cells. Detection of
total b-catenin antigen in WT tail skin (A) and tumor (B) through standard IHC. Note that total b-catenin antigen is down-regulated in the
tumor. (C&D) show that phosphorylated b-catenin is down-regulated in tumor cells. Detection of phosphorylated b-catenin antigen in WT tail
skin (A) and tumor (B) through standard IHC. Note that phosphorylated b-catenin antigen is down-regulated in the tumor. (E&F) show that active
b-catenin is up-regulated in a subpopulation of cells. Detection of active b-catenin antigen in WT tail skin (A) and tumor (B) through standard
IHC. Note that active b-catenin antigen is up-regulated in a small population of cells, and slightly down-regulated or unchanged in the majority
of tumor cells. (G) double staining found that high levels of stable b-catenin almost exclusively co-localized with a dermal papillae marker (ALP).
G’&G ” are the split channels of active b-catenin and ALP, respectively. Bar = 40 μm.
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herin with an associated inhibition of hair progenitor cell
differentiation. Factors that affect cell migration, such as
CD44, are also dynamically regulated which may enable
newly generated cells to migrate to form tumors. Under-
standing the precise roles of BMP signaling in each cell
type in the skin will hopefully lead to the development of
new therapeutic approaches for using agonist or antago-
nists of BMP signaling in the treatment of skin and hair
growth disorders, such as trichofolliculoma.
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